This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A MUCH STRONGER public-private partnership is needed if a safe, effective vaccine against the human immunodeficiency virus (HIV) is going to be developed, says a new report entitled Industry Investment in HIV Vaccine Research.
The AIDS Vaccine Advocacy Coalition (AVAC) in San Francisco, Calif, which released the report on World AIDS Day, says working relationships between government and industry have improved in recent years, but many deficits remain. In fact, the report's authors call government leadership the "key ingredient" needed to expedite the creation of a successful vaccine.
"We were surprised to learn that, in most cases, government is the engine that drives industry and that industry research depends on government financing, government leadership, and government support," said Chris Collins, MPP, an author of the report and policy specialist at the Center for AIDS Prevention Studies at the University of California at San Francisco.
Baltimore Appointment Hailed
About a week
Voelker R. Collaboration Needed for HIV Vaccine Success. JAMA. 1997;277(1):9. doi:10.1001/jama.1997.03540250017009